NANOG, SOX2, and OCT4 (octamer‐binding transcription factor 4) are key regulators of pluripotency and tumor invasion, and they have been proposed as biomarkers for cancer stemness in breast and renal carcinoma (Ponti et al, 2005; Rasti et al, 2018). This evidence concerns the gene SOX2 and renal carcinoma.